New Zealand Gastrointestinal Diseases Drug Development Market (2025-2031) | Competitive Landscape, Companies, Industry, Segmentation, Outlook, Analysis, Forecast, Size & Revenue, Trends, Growth, Value, Share
Market Forecast By Disease Type (Gastroenteritis, Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome, Others), By Molecular Targets (Sodium Transporter NHE3 Inhibitor, Sphinogosine-1-Phosphate Receptor Functional Antagonist, Tumor Necrosis Factor (TNF) Blocker, Others), By Marketed Drugs (Infliximab, Adalimumab, Mesalazine, Others), By Clinical Trials (Etrolizumab, SHP647, ABX464, ASP3291, Others), By Route of Administration (Oral, Injectable), By End-Users (Hospitals, Homecare, Specialty Clinics) And Competitive Landscape
| Product Code: ETC8560834 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Key Highlights of the Report:
- New Zealand Gastrointestinal Diseases Drug Development Market Outlook
- Market Size of New Zealand Gastrointestinal Diseases Drug Development Market, 2024
- Forecast of New Zealand Gastrointestinal Diseases Drug Development Market, 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Revenues & Volume for the Period 2021- 2031
- New Zealand Gastrointestinal Diseases Drug Development Market Trend Evolution
- New Zealand Gastrointestinal Diseases Drug Development Market Drivers and Challenges
- New Zealand Gastrointestinal Diseases Drug Development Price Trends
- New Zealand Gastrointestinal Diseases Drug Development Porter's Five Forces
- New Zealand Gastrointestinal Diseases Drug Development Industry Life Cycle
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Disease Type for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Gastroenteritis for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Inflammatory Bowel Disease (IBD) for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Irritable Bowel Syndrome for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Molecular Targets for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Sodium Transporter NHE3 Inhibitor for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Sphinogosine-1-Phosphate Receptor Functional Antagonist for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Tumor Necrosis Factor (TNF) Blocker for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Marketed Drugs for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Infliximab for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Adalimumab for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Mesalazine for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Clinical Trials for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Etrolizumab for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By SHP647 for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By ABX464 for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By ASP3291 for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Route of Administration for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Oral for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Injectable for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By End-Users for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Hospitals for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Homecare for the Period 2021- 2031
- Historical Data and Forecast of New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
- New Zealand Gastrointestinal Diseases Drug Development Import Export Trade Statistics
- Market Opportunity Assessment By Disease Type
- Market Opportunity Assessment By Molecular Targets
- Market Opportunity Assessment By Marketed Drugs
- Market Opportunity Assessment By Clinical Trials
- Market Opportunity Assessment By Route of Administration
- Market Opportunity Assessment By End-Users
- New Zealand Gastrointestinal Diseases Drug Development Top Companies Market Share
- New Zealand Gastrointestinal Diseases Drug Development Competitive Benchmarking By Technical and Operational Parameters
- New Zealand Gastrointestinal Diseases Drug Development Company Profiles
- New Zealand Gastrointestinal Diseases Drug Development Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6Wresearch actively monitors the New Zealand Gastrointestinal Diseases Drug Development Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the New Zealand Gastrointestinal Diseases Drug Development Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Gastrointestinal Diseases Drug Development Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Gastrointestinal Diseases Drug Development Market - Industry Life Cycle |
3.4 New Zealand Gastrointestinal Diseases Drug Development Market - Porter's Five Forces |
3.5 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Molecular Targets, 2021 & 2031F |
3.7 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Marketed Drugs, 2021 & 2031F |
3.8 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Clinical Trials, 2021 & 2031F |
3.9 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 New Zealand Gastrointestinal Diseases Drug Development Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastrointestinal diseases in New Zealand |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of gastrointestinal diseases |
4.2.3 Technological advancements in drug development for gastrointestinal diseases |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new drugs in New Zealand |
4.3.2 High cost associated with research and development of new drugs |
4.3.3 Limited availability of skilled professionals in the field of gastrointestinal drug development |
5 New Zealand Gastrointestinal Diseases Drug Development Market Trends |
6 New Zealand Gastrointestinal Diseases Drug Development Market, By Types |
6.1 New Zealand Gastrointestinal Diseases Drug Development Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Gastroenteritis, 2021- 2031F |
6.1.4 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Inflammatory Bowel Disease (IBD), 2021- 2031F |
6.1.5 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Irritable Bowel Syndrome, 2021- 2031F |
6.1.6 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Others, 2021- 2031F |
6.2 New Zealand Gastrointestinal Diseases Drug Development Market, By Molecular Targets |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Sodium Transporter NHE3 Inhibitor, 2021- 2031F |
6.2.3 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Sphinogosine-1-Phosphate Receptor Functional Antagonist, 2021- 2031F |
6.2.4 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Tumor Necrosis Factor (TNF) Blocker, 2021- 2031F |
6.2.5 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Others, 2021- 2031F |
6.3 New Zealand Gastrointestinal Diseases Drug Development Market, By Marketed Drugs |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Infliximab, 2021- 2031F |
6.3.3 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Adalimumab, 2021- 2031F |
6.3.4 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Mesalazine, 2021- 2031F |
6.3.5 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Others, 2021- 2031F |
6.4 New Zealand Gastrointestinal Diseases Drug Development Market, By Clinical Trials |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Etrolizumab, 2021- 2031F |
6.4.3 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By SHP647, 2021- 2031F |
6.4.4 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By ABX464, 2021- 2031F |
6.4.5 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By ASP3291, 2021- 2031F |
6.4.6 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Others, 2021- 2031F |
6.5 New Zealand Gastrointestinal Diseases Drug Development Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Injectable, 2021- 2031F |
6.6 New Zealand Gastrointestinal Diseases Drug Development Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 New Zealand Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 New Zealand Gastrointestinal Diseases Drug Development Market Import-Export Trade Statistics |
7.1 New Zealand Gastrointestinal Diseases Drug Development Market Export to Major Countries |
7.2 New Zealand Gastrointestinal Diseases Drug Development Market Imports from Major Countries |
8 New Zealand Gastrointestinal Diseases Drug Development Market Key Performance Indicators |
8.1 Number of new drug approvals for gastrointestinal diseases in New Zealand |
8.2 Investment in research and development for gastrointestinal drug development |
8.3 Number of clinical trials conducted for gastrointestinal drugs in New Zealand |
9 New Zealand Gastrointestinal Diseases Drug Development Market - Opportunity Assessment |
9.1 New Zealand Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 New Zealand Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Molecular Targets, 2021 & 2031F |
9.3 New Zealand Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Marketed Drugs, 2021 & 2031F |
9.4 New Zealand Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Clinical Trials, 2021 & 2031F |
9.5 New Zealand Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 New Zealand Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 New Zealand Gastrointestinal Diseases Drug Development Market - Competitive Landscape |
10.1 New Zealand Gastrointestinal Diseases Drug Development Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Gastrointestinal Diseases Drug Development Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Pricing
- Single User License$ 1,995
- Department License$ 2,400
- Site License$ 3,120
- Global License$ 3,795
Search
Thought Leadership and Analyst Meet
Our Clients
Related Reports
- South Africa Stationery Market (2025-2031) | Share, Size, Industry, Value, Growth, Revenue, Analysis, Trends, Segmentation & Outlook
- Afghanistan Rocking Chairs And Adirondack Chairs Market (2026-2032) | Size & Revenue, Competitive Landscape, Share, Segmentation, Industry, Value, Outlook, Analysis, Trends, Growth, Forecast, Companies
- Afghanistan Apparel Market (2026-2032) | Growth, Outlook, Industry, Segmentation, Forecast, Size, Companies, Trends, Value, Share, Analysis & Revenue
- Canada Oil and Gas Market (2026-2032) | Share, Segmentation, Value, Industry, Trends, Forecast, Analysis, Size & Revenue, Growth, Competitive Landscape, Outlook, Companies
- Germany Breakfast Food Market (2026-2032) | Industry, Share, Growth, Size, Companies, Value, Analysis, Revenue, Trends, Forecast & Outlook
- Australia Briquette Market (2025-2031) | Growth, Size, Revenue, Forecast, Analysis, Trends, Value, Share, Industry & Companies
- Vietnam System Integrator Market (2025-2031) | Size, Companies, Analysis, Industry, Value, Forecast, Growth, Trends, Revenue & Share
- ASEAN and Thailand Brain Health Supplements Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- ASEAN Bearings Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Europe Flooring Market (2025-2031) | Outlook, Share, Industry, Trends, Forecast, Companies, Revenue, Size, Analysis, Growth & Value
Industry Events and Analyst Meet
Stationery & Paper Expo Saudi Arabia 2026
Kids & Toys Expo Saudi Arabia 2026
Gifts & Homeware Expo Saudi Arabia 2026
Smart Home Expo 2026
Industrial Facilities Management Expo 2025
Whitepaper
- Middle East & Africa Commercial Security Market Click here to view more.
- Middle East & Africa Fire Safety Systems & Equipment Market Click here to view more.
- GCC Drone Market Click here to view more.
- Middle East Lighting Fixture Market Click here to view more.
- GCC Physical & Perimeter Security Market Click here to view more.
6WResearch In News
- Doha a strategic location for EV manufacturing hub: IPA Qatar
- Demand for luxury TVs surging in the GCC, says Samsung
- Empowering Growth: The Thriving Journey of Bangladesh’s Cable Industry
- Demand for luxury TVs surging in the GCC, says Samsung
- Video call with a traditional healer? Once unthinkable, it’s now common in South Africa
- Intelligent Buildings To Smooth GCC’s Path To Net Zero
